Suppr超能文献

放疗后 10 多年的前列腺癌患者生活质量——治疗后时间和处方剂量的影响。

Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose.

机构信息

Department of Radiation Oncology, RWTH Aachen University, Pauwelsstrasse 30, 52072, Aachen, Germany.

Department of Radiation Oncology, MediClin Robert Janker Klinik, Villenstr. 8, 53129, Bonn, Germany.

出版信息

Qual Life Res. 2021 Feb;30(2):437-443. doi: 10.1007/s11136-020-02639-7. Epub 2020 Oct 9.

Abstract

PURPOSE

Analysis of quality of life changes after radiotherapy with focus on the impact of time after treatment and prescription dose.

METHODS

Consecutive patients were treated with doses from 70.2/1.8 Gy (n = 206) to 72/1.8-2.0 Gy (n = 176) in a single centre and surveyed using the Expanded Prostate Cancer Index Composite questionnaire.

RESULTS

Urinary and bowel bother scores decreased 1 / 3 / 6 points and 7 / 7 / 9 points on average 1 / 5 / 10 years after RT in comparison to baseline scores. The rate of urinary (need of pads in 8% vs. 15% before vs. 10 years after RT; p = 0.01) and bowel (uncontrolled leakage of stool in 5% vs. 12% before vs. 10 years after RT; p < 0.01) incontinence, as well as rectal bleeding (4% vs. 8% before vs. 10 years after RT; p = 0.05) increased. Sexual function scores decreased (erections sufficient for intercourse in 36% vs. 12% before vs. 10 years after RT; p < 0.01). A higher dose had a statistically significant impact on urinary bother and stool incontinence, but also tended to decrease urinary continence. Age and comorbidities did not have an influence on score changes, but on baseline urinary function/bother and baseline sexual function.

CONCLUSION

Apart from an increasing rate of erectile dysfunction, urinary and bowel incontinence rates increased with increasing follow-up period. A higher dose was found to be associated with increased urinary problems and larger stool incontinence rates. Age and comorbidities were found to be relevant for baseline scores, but not for score changes.

摘要

目的

分析放疗后生活质量的变化,重点关注治疗后时间和处方剂量的影响。

方法

在一个中心,连续的患者接受了从 70.2/1.8 Gy(n=206)到 72/1.8-2.0 Gy(n=176)的剂量治疗,并使用扩展前列腺癌指数综合问卷进行了调查。

结果

与基线评分相比,在 RT 后 1/5/10 年,尿和肠困扰评分平均分别降低了 1/3/6 分和 7/7/9 分。尿失禁(使用尿垫的比例分别为 8%、15%和 10 年后 RT;p=0.01)和肠失禁(无法控制的粪便泄漏的比例分别为 5%、12%和 10 年后 RT;p<0.01)以及直肠出血(4%、8%和 10 年后 RT;p=0.05)的发生率增加。性功能评分下降(勃起足以进行性交的比例分别为 36%、12%和 10 年后 RT;p<0.01)。更高的剂量对尿困扰和大便失禁有统计学显著影响,但也倾向于降低尿控。年龄和合并症对评分变化没有影响,但对基线尿功能/困扰和基线性功能有影响。

结论

除了勃起功能障碍的发生率增加外,随着随访时间的延长,尿失禁和肠失禁的发生率也在增加。更高的剂量与更多的尿问题和更大的大便失禁率有关。年龄和合并症与基线评分相关,但与评分变化无关。

相似文献

10

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验